Haemonetics

Yahoo Finance • 2 months ago

Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025

We recently published a list of 10 Worst Affordable Stocks To Buy Right Now. In this article, we are going to take a look at where Haemonetics Corporation (NYSE:HAE) stands against other worst affordable stocks to buy right now. How is th... Full story

Yahoo Finance • 9 months ago

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 45th Annual Institutional Investors Conference... Full story

Yahoo Finance • 9 months ago

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at Citi's 2024 Unplugged Medtech and Life Sciences Access Day on Th... Full story

Yahoo Finance • 9 months ago

25 Most Valuable Medical Device Companies in the US

In this article, we will be taking a look at the 25 most valuable medical device companies in the US. If you are not interested in learning about the emerging trend in medical device industry, head straight to the 5 Most Valuable Medical D... Full story

Yahoo Finance • 9 months ago

Haemonetics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Haemonetics (NYSE:HAE) Third Quarter 2024 Results Key Financial Results Revenue: US$336.3m (up 10% from 3Q 2023). Net income: US$31.2m (down 5.2% from 3Q 2023). Profit margin: 9.3% (down from 11% in 3Q 2023). The decrease in margin was d... Full story

Yahoo Finance • 9 months ago

Q3 2024 Haemonetics Corp Earnings Call

Participants Olga Guyette; Director, IR; Haemonetics Corporation Chris Simon; President and CEO; Haemonetics Corporation James D'Arecca; EVP, CFO; Haemonetics Corporation Presentation Operator Good day, and thank you for standing by.... Full story

Yahoo Finance • 9 months ago

Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Financial release accessible online BOSTON, Feb. 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2024, which ended December 30, 2023, are available on its Inve... Full story

Yahoo Finance • 10 months ago

The three-year underlying earnings growth at Haemonetics (NYSE:HAE) is promising, but the shareholders are still in the red over that time

Many investors define successful investing as beating the market average over the long term. But the risk of stock picking is that you will likely buy under-performing companies. We regret to report that long term Haemonetics Corporation (... Full story

Yahoo Finance • 10 months ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024

BOSTON, Jan. 11, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2024 financial results at 6:00 am ET on Thursday, February 8, 2024. The Company will hold a c... Full story

Yahoo Finance • 2 years ago

These Two Stocks Make New Highs, Hold In Buy Zones

New highs are rare for stocks when major indexes hit resistance. Yet HAE and LECO are climbing to 52-week highs and are in buy zones. Continue reading... Full story

Yahoo Finance • 2 years ago

Haemonetics to Present at 41st Annual J.P. Morgan Healthcare Conference

BOSTON, Dec. 19, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 10, 2023 at 2:1... Full story

Yahoo Finance • 2 years ago

Is Haemonetics Corporation's (NYSE:HAE) 12% ROE Better Than Average?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine Haemonetics Corporation (NYSE:H... Full story

Yahoo Finance • 2 years ago

Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Financial release accessible online BOSTON, Aug. 10, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2023, which ended July 2, 2022, are available on its Investor Rela... Full story

Yahoo Finance • 2 years ago

Here's Why You Should Retain Haemonetics (HAE) Stock For Now

Haemonetics Corporation HAE is gaining from strength in the Hospital business. Robust growth across the company’s most extensive hospital product line, Hemostasis Management, seems encouraging. The ongoing rebound in plasma collections buo... Full story

Yahoo Finance • 2 years ago

Should Haemonetics Corporation (NYSE:HAE) Focus On Improving This Fundamental Metric?

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. We'll use ROE to examine Haemonetics Co... Full story

Yahoo Finance • 3 years ago

Estimating The Intrinsic Value Of Haemonetics Corporation (NYSE:HAE)

In this article we are going to estimate the intrinsic value of Haemonetics Corporation (NYSE:HAE) by estimating the company's future cash flows and discounting them to their present value. One way to achieve this is by employing the Disco... Full story